You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動丨暴漲800%“妖股”九安醫療回吐近6% “白菜價”推股權激勵
格隆匯 01-05 09:47
格隆匯1月5日丨近期的兩市第一妖股九安醫療(002432.SZ)跌近6%,報48.8元,總市值234億元。九安醫療昨晚公吿,向符合條件的353名激勵對象授予股票期權737萬份,行權價格為6.49元/股。由於新冠抗原家用自測試劑盒在美國熱銷預期,九安醫療股價從去年11月15日開始狂飆,先是來了一波11天10漲停,隨後又來了一波14天11漲停,兩個月漲幅達到8倍,截止昨日收盤報51.85元/股。這也意味着公司股票期權甫一授出,獲利空間就達到了7倍,727萬份期權總獲利空間3.34億元,人均達95萬元。行權條件來看,第一個行權期2022年營收較2019年增長不低於40%,而2021前三季度較2019年前三季度已經增長了54%,也就是説2022年只要能維持住2021年的營收,即可達到行權條件。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account